Facultad de Farmacia
Facultad de Farmacia

Actividades

Seminarios de Investigación

Los Seminarios de Investigación son una serie de Conferencias y Jornadas (en español y en inglés) que se organizan desde la Facultad de Farmacia y que permiten a los alumnos adquirir conocimientos en diferentes Áreas y complementar así el programa formativo de acuerdo con el interés profesional del alumno, además de consolidar su destreza en el idioma inglés

Responsable: Nuria del Olmo Izquierdo

Fecha Ponente  Tema
25 de octubre de 2016 Nuria Montserrat Dreaming with organ regeneration: new hopes for regenerative medicine
12 de diciembre de 2016 David Baeza La investigación en una pyme
19 de diciembre de 2016 Carmen González Martín Puesta a punto de una Unidad de Investigación Traslacional
30 de enero de 2017 Peter F. Hitchcock Identifying drug targets that will inhibit CNS degeneration or stimulate CNS regeneration
6 de febrero de 2017 Lourdes Samaniego La fortificación de los alimentos con ácido fólico como medida de salud pública: luces y sombras
13 de febrero de 2017 Nuria del Olmo Efectos de la administración intermitente y excesiva de alcohol en los procesos de aprendizaje y memoria
20 de febrero de 2017 Lucciana Vaccaro Primeros casos de Legionella no-pneumophila
23 de febrero de 2017 Josefa Zaldívar Las aventuras de una estudiante del CEU en Harvard
27 de febrero de 2017 Maria Isabel Panadero Fructosa y programación fetal del síndrome metabólico
6 de marzo de 2017 Javier Pérez Castell Síntesis de azúcares coordinados con lantánidos y su uso para investigar los procesos de interacción entre proteínas y carbohidratos
13 de marzo de 2017 Mariano Ruiz-Gayo Papel de la colecistoquinina en el metabolismo del tejido adiposo
27 de marzo de 2017 Coral Barbas Por confirmar
3 de abril de 2017 Pedro Antonio Jiménez Multirresistencia a Antibióticos y modulación Quorum sensing – Quorum Quenching
24 de abril de 2017 Sara Bueno Control de la miopía con lentes de contacto
8 de mayo de 2017 Luis Fernando Alguacil Adicción a los opiáceos

Cursos y redes

  • COST Action – BM1003 Microbial cell surface determinants of virulence as targets for new therapeutics in Cystic Fibrosis
    The main aim of BM1003 action is to create an integrated network of excellence involving collaboration between experts in the multi-disciplinary fields of science required for understanding microbial cell surface determinants of virulence, antibiotic resistance and inflammation.

    Cystic fibrosis disease
    Cystic fibrosis (CF) causes constitutive inflammation in many organs and it particularly affects the lung. Chronic airway inflammation with chronic bacterial infections becomes established in most patients and it may lead to lung damage, destruction and eventually death. The bacterial factors and the molecular mechanisms which provoke inflammation in the respiratory epithelium of cystic fibrosis patients remain unclear. This topic is tackled using a coordinated and interdisciplinary approach by joining efforts by 16 European Countries, being Universidad CEU San Pablo member of the Management Committee. Competencies range from chemistry to microbiology and medicine. This multi- and inter-disciplinary approach is aimed at enabling the development of novel antibacterial inhibitors for anti-inflammatory therapy in cystic fibrosis patients.

    Reasons for the Action
    The major reasons for launching this Action are to rapidly develop novel therapies for CF and non-CF patient groups at risk for lung infections with opportunistic Gram-positive and Gram-negative bacterial pathogens. This aim will be achieved by the coordination of researchers into a European network of the already funded national research. Networking will also avoid repetition or duplication of scientific work and thus spare valuable resources of prior isolated research groups in Europe. We will create a defined panel of clinically relevant bacterial pathogens as an open user resource. This COST Action will enable researchers to develop novel inhibitors of bacterial cell wall synthesis with the aim to reduce lung inflammation in CF airways and to eradicate the pathogens with novel treatment strategies. This will increase the life expectancy of the CF patients. The pathogens that will be studied are also known to affect other patient groups including patients with immunodeficiencies such as burns patients and ventilated patients in critical care units. Also in these large patient groups, mortality due to respiratory infections is high. Improvement in knowledge of bacterial pathogenesis would have important implications for these patient groups, the quality of life of affected individual, and with the potential to reduce the inappropriate use of currently administered antibiotics, which increase the number of resistant pathogens in the European community.

Actividades

Olimpiadas de Química (Edición XXXIV)

Olimpiadas de Química XXXIV Edición